# Optimal Margin Evaluation of Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer

> **NCT05682950** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 15 (actual)

## Conditions studied

- Uterine Cervical Neoplasm
- Endometrial Neoplasms

## Interventions

- **RADIATION:** online adaptive radiotherapy

## Key facts

- **NCT ID:** NCT05682950
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-09-12
- **Primary completion:** 2023-02-06
- **Final completion:** 2025-02
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2024-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05682950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05682950, "Optimal Margin Evaluation of Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05682950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*